The TGA has approved SAS applications including, but not limited to, the following:
Most medicinal cannabis products are classified as ‘unapproved’ products and are not available as registered prescription medicines. This means the pathways to gain access are different from normal prescription medications.
Kind medicinal cannabis products are available with an approved prescription via the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS-B) or through Authorised Prescriber applications. The TGA has a wealth of information and resources for healthcare professionals to reference on how to access medicinal cannabis, starting here. Below we have provided a brief summary.
Authorised Prescribers are doctors who have met the TGA’s requirements and been approved as an Authorised Prescriber. Authorised Prescribers do not need separate approval to prescribe medicinal cannabis to patients under their care.
The TGA outlines requirements to become an Authorised Prescriber. Applications can be lodged via the TGA’s online portal. There are also other independent groups that teach healthcare professionals how to become a prescriber, such as CanView’s Medical Professional Support portal.
To prescribe a patient medicinal cannabis you must first obtain an SAS-B approval from the TGA for them, unless you are an Authorised Prescriber (see below). SAS-B requests normally take around two days to be approved, after which time you can issue the patient’s medicinal cannabis prescription for fulfilment at their pharmacy.
SAS-B applications can be lodged via the TGA’s medicinal cannabis SAS-B portal or via other platforms like CanView’s Medical Professional Support portal. TGA and state or territory health department authorisations can be applied for simultaneously. The request process is streamlined enough that we suggest completing it during your patient’s visit.
Some information you’ll need is as follows:
There are no restrictions on the medical conditions for which a prescriber may apply via the SAS to access an unapproved medicinal cannabis product for their patient, provided the prescriber has the appropriate knowledge of the condition being treated and the medicinal cannabis product they wish to prescribe.